Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)

$496K USD

Funder	National Institutes of Health
Recipient Organization	Not specified
Country	USA
Start Date	Dec 10, 2024
End Date	Mar 04, 2030
Duration	1,910 days
Number of Grantees	1
Data Source	Grants.gov
Grant ID	`36fa146e-a461-4128-99a4-a65bc83aa928`

Grant Description

Through this engineering-oriented Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility.